US20220401498A1 - USE OF FAECALIBACTERIUM PRAUSNITZII IN PREPARATION OF MEDICINE FOR TREATING PATHOLOGICAL VENTRICULAR REMODELING AND/OR HEART FAILURE FOLLOWING MYOCARDIAL INFARCTION